Custom-Made vaccine aims to fight aggressive brain cancer
Disease control
Not yet recruiting
This study is testing whether adding a personalized vaccine to standard chemotherapy helps control glioblastoma, an aggressive brain cancer, after initial surgery and radiation. The vaccine is made from the patient's own immune cells and tumor proteins. Researchers will compare h…
Phase: PHASE2 • Sponsor: ZSky Biotech Inc • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC